ECSP982704A - PROLONGED RELEASE FORMULA - Google Patents
PROLONGED RELEASE FORMULAInfo
- Publication number
- ECSP982704A ECSP982704A ECSP982704A ECSP982704A EC SP982704 A ECSP982704 A EC SP982704A EC SP982704 A ECSP982704 A EC SP982704A EC SP982704 A ECSP982704 A EC SP982704A
- Authority
- EC
- Ecuador
- Prior art keywords
- formula
- tablets
- prolonged release
- hydrochloride
- release formula
- Prior art date
Links
- 230000002035 prolonged effect Effects 0.000 title 1
- 238000013265 extended release Methods 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 229960002416 venlafaxine hydrochloride Drugs 0.000 abstract 1
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
El presente invento se relaciona con una fórmula posológica y dosis unitaria de la misma, de clorhidrato de venlafazina, un agente antidepresivo, de liberación prolongada sobre 24 horas, que ofrece un control de las concentraciones plasmaticas mejor que el de la fórmula convencionales en tabletas que deberán administrarse dos o más veces al dia, y que también se asocia con una incidencia más baja de náuseas y vómitos que las tabletas convencionales. En su aspecto principal, este invento proporciona una mejor fórmula de los esferoides de liberación prolongada compuesta de clorhidrato de venlafaxina y celulosa microcristalina, que es, sin la adición de hidroxi-propil-metilcelulosa.The present invention relates to a dosage formula and unit dose thereof, of venlafazine hydrochloride, an antidepressant agent, extended release over 24 hours, which offers better control of plasma concentrations than the conventional formula in tablets that They should be administered two or more times a day, and that is also associated with a lower incidence of nausea and vomiting than conventional tablets. In its main aspect, this invention provides a better extended-release spheroidal formula composed of venlafaxine hydrochloride and microcrystalline cellulose, which is, without the addition of hydroxy-propyl-methylcellulose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982704 ECSP982704A (en) | 1998-10-22 | 1998-10-22 | PROLONGED RELEASE FORMULA |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982704 ECSP982704A (en) | 1998-10-22 | 1998-10-22 | PROLONGED RELEASE FORMULA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982704A true ECSP982704A (en) | 1999-04-16 |
Family
ID=42043622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982704 ECSP982704A (en) | 1998-10-22 | 1998-10-22 | PROLONGED RELEASE FORMULA |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982704A (en) |
-
1998
- 1998-10-22 EC ECSP982704 patent/ECSP982704A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PY970019A (en) | EXTENDED-RELEASE FORMULA | |
| UY25234A1 (en) | VENLAFAXINE PROLONGED RELEASE FORMULATION | |
| ES2530719T3 (en) | Oxycodone formulations to be administered once a day | |
| CY1108426T1 (en) | ORAL FORMS OF ADMINISTRATION FOR ADMINISTRATIVE OR PHARMACEUTICAL SALTS | |
| MX9302867A (en) | REFRESHING COMPOSITIONS. | |
| CY1106541T1 (en) | PHARMACEUTICAL COMPOSITION AND USE OF R-NSAID TO TREAT INFLAMMATION | |
| ATE460157T1 (en) | EXTENDED-RELEASE PHARMACEUTICAL METFORMINT TABLET | |
| ES2191987T3 (en) | DOSAGE FORMS OF RIBAVIRINA SOLIDAS, ADMINISTRABLE ORALALLY, AND MANUFACTURING PROCEDURE. | |
| CO5190674A1 (en) | TREATMENT OF NEUROTIC DISORDERS NEUROTIC DISORDERS | |
| ES2305567T3 (en) | FORMULATIONS OF RELEASE OF SUSTAINED LIBERATION WITH EFFECTIVENESS OF 24 HOURS. | |
| AR036321A1 (en) | METHOD AND PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF LATE APPEARANCE DYSCINESIA. | |
| ECSP982704A (en) | PROLONGED RELEASE FORMULA | |
| AR016473A1 (en) | EFFECTIVE PREPARATION AND PROCEDURE FOR PREPARATION | |
| ECSP972046A (en) | PROLONGED RELEASE FORMULA | |
| ES2188232T3 (en) | USE OF CETIRIZINE TO PREVENT THE APPEARANCE OF ASTHMA. | |
| ATE301469T1 (en) | PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE | |
| GT200000187A (en) | A COMBINATION CASE USED IN THE TREATMENT OF PALUDISM. | |
| BR0312333A (en) | Combination therapy and agent for its execution | |
| AR043129A1 (en) | COMBINATION OF ANTIDIABETIC PHARMACOS | |
| BR9912260A (en) | Plaster containing a transdermal therapeutic system and a single dose for administration | |
| AR022475A1 (en) | METHOD FOR THE PREVENTION OR REDUCTION OF CARDIOVASCULAR EVENTS ASSOCIATED WITH CORONARY INTERVENTION. | |
| KR970000231A (en) | Pharmaceutical composition of analgesic anti-inflammatory |